Abstract
Interferon gamma (IFN-γ) and interleukin 6 (IL-6) are including the most important cytokines which have been associated with the biological behavioral and immune responses in malignancies. Based on the critical roles which these two cytokines play against tumor cells, the present study was aimed to investigate the genes expression level of IL6 and IFN-γ in patients with Acute Lymphoblastic Leukemia and compare with normal controls. Fifty-two patients with ALL and 13 healthy volunteer were under studied. The peripheral blood mononuclear cells of all patients and normal controls were separated by ficoll. The expression of interferon gamma and interleukin 6 genes were determined by RQ-PCR. Finally all data were analyzes using T student, one way ANOVA and Mann-Whitney tests were use to analyze all samples data. Our finding showed that the level of IFN-γ gene expression was significant decreased in patients with All as compared with healthy controls (83 change fold, p < 0.0001). The level of IL-6 Gene expression was not changeable in B-ALL patients as compared with healthy control (p = 0.4), but in T-ALL patients, was significantly reduced (p < 0.01). The results of present study indicated that IFN-γ gene expression reduced in ALL patients. It provides a valuable insight that immune system may disrupted in patients with ALL, which cause tumor cells escape from immune surveillance.
Similar content being viewed by others
References
Harrison CJ (2013) Targeting signaling pathways in acute lymphoblastic leukemia: new insights. American Society of Hematology, Education Program 2013(1):118–125
Cardoso B, Gírio A, Henriques C, Martins L, Santos C, Silva A et al (2008) Aberrant signaling in T-cell acute lymphoblastic leukemia: biological and therapeutic implications. Braz J Med Biol Res 41(5):344–350
Brady MT, Lee J, Ferrone S et al (2011) Interferon-γ secretion by t(9;22) acute lymphoblastic leukemia- derived dendritic cells. American Society of Hematology, Education Program 35(2):275–277
Kholoussi SM, Bayoumi FS, El-Nady H (2008) Estimation of serum interferon-gamma level in childhood acut lymphoblastic leukemia patients. J Med Sci 8(1):68–72
Marth C, Fiegl H, Zeimet AG et al (2004) Interferon-g expression is an independent prognostic factor in ovarian cancer. Am J Obstet Gynecol 191:1598–1605
Tian G, Mi J, Wei X, Zhao D, Qiao L, Yang C, Li X et al (2015) Circulating interleukin-6 and cancer: a meta-analysis using Mendelian randomization. Sci Rep
Heikkila K, Ebrahim S, Lawlor DA (2008) Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer 44:937–945
Sugiyama H, Inoue K, Ogawa H, Yamagami T, Soma T, Miyake S, Hirata M, Kishimoto T (1995) The expression of IL-6 and its related genes in acute leukemia. Leuk Lymphoma 21:1
Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. J Biochem 374(1):1–20
Bauvois B, Nguyen J, Tang R, Billard C, Kolb J-P (2009) Types I and II interferon supregulate the co-stimulatory CD80 molecule in monocytes via interferon regulatory factor. Biochem Pharmacol 8(5):514–522
Sato A, Ohtsuki M, Hata M et al (2006) Antitumor activity of IFN- in murine tumor models. J Immunol 176:7686–7694
Fujii H, Trudeau JD, Teachey DT, Fish JD, Stephan A et al (2007) In vivo control of acute lymphoblastic leukemia by immuno stimulatory Cp Goligonucleotides. Blood 1090:5.2008–5.2013
Yin HQ, Qiao ZH, Zhu L, Zhang L, Su LP, Lu YJ (2006) Levels of intracellular IL-6 and IFN-gamma in children with acute lymphoblastic leukemia. American Society of Hematology, Education Program 8(6):461–463
HeePark H, Kim M, Lee B-H et al (2006) Intracellular IL-4, IL-10, and IFN-γ levels of leukemic cells and bone marrow T cells in acute leukemia. Ann Clin Lab Sci 36:15–17
Zhang X-I, Komada Y, Joe C (2000) Intracellular cytokine pro®le of T cells with acute lymphoblastic leukemia. Cancer Immunol Immunother 49(3):165–172
Strander H (1986) Interferon treatment of human neoplasia. Adv Cancer Res 46:1
De Maeyer E, De Maeyer-Guignard J (1988) Interferons and other regulatory cytokines. Wiley, New York, pp 134–334
Grandér D, Heyman M, Brondum-Nielsen K, Liu Y, Lundgren E, Soderhall S, Einhorn S (1992) Interferon system in primary acute lymphocytic leukemia cells with or without deletions of the <w-/P-interferon genes. Blood 79(8):2076–2083
Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K (2005) Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia. Cancer 103(4):1054–1063
Morales T, Rojas NV et al (2012) Proinflammatory cytokines during the initial phase of oralmucositis in patients with acute lymphoblastic leukaemia. Int J Paediatr Dent 22:191–196
Luo Y, Huang Z, Qian H et al (1993) Tumor necrosis factor and interleukin 6 in acute leukemia. Zhonghua nei ke za zhi 32(2):85–87
Pituch-Noworolska A, Wieckiewicz J, Gawlicka M et al (1998) The IL-6 gene expression by leukemic cells from acute lymphoblastic leukemia common and T type and modulation of IL-6 production by TNF. Haematologia 29(2):101–114
Sanchez-Correa B, Berqua JM, Campos C et al (2013) Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine 61(3):885–891
Acknowledgments
Authors would like to thank the deputy research of Shahid Beheshti University of medical Science (School of Allied medical Sciences) for supporting and providing research facilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Rights and permissions
About this article
Cite this article
Allahbakhshian Farsani, M., Kamel, M., Mehrpouri, M. et al. The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL). Pathol. Oncol. Res. 26, 461–466 (2020). https://doi.org/10.1007/s12253-018-0536-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-018-0536-z